13G Filing: Armistice Capital and Novelion Therapeutics Inc. (NVLN)

Page 3 of 10 – SEC Filing

CUSIP No
67001K202
1.
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Armistice Capital Master Fund Ltd.
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)  [_]
(b)  [X]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER
0
6.
SHARED VOTING POWER
1,852,000
7.
SOLE DISPOSITIVE POWER
0
8.
SHARED DISPOSITIVE POWER
1,852,000
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,852,000
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      [_]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.96%
12.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)